Apolipoprotein e gene polymorphism and serum lipid profile in Saudi patients with psoriasis

Disease Markers

Volumn 2014, Issue , 2014, Pages

  Harthi, Fahad Al ^a   Huraib, Ghaleb Bin ^a   Zouman, Abdulrahman ^a   Arfin, Misbahul ^b   Tariq, Mohammad ^b   Al Asmari, Abdulrahaman ^b  

^a The General Directorate of Armed Forces Health Services   (Saudi Arabia)

^b Clinical Research Center   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; APOE GENE; ARTICLE; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENDER; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; GLUCOSE BLOOD LEVEL; HETEROZYGOTE; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; RISK FACTOR; SAUDI ARABIA; TEST STRIP; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84896978402     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2014/239645     Document Type: Article

References (69)

1. M. Icen, C. S. Crowson, M. T. McEvoy, F. J. Dann, S. E. Gabriel, andH. M. Kremers, "Trends in incidence of adult-onset psoriasis over three decades: a population-based study, " Journal of the American Academy ofDermatology, vol. 60, no. 3, pp. 394- 401, 2009.
2. E. M. Farber andM. L. Nall, "The natural history of psoriasis in 5, 600 patients, " Dermatologica, vol. 148, no. 1, pp. 1-18, 1974.
3. E. Christophers and U. Mrowietz, "Psoriasis, " in Fitzpatricks Dermatology in GeneralMedicine, McGraw-Hill, New York, NY, USA, 2003.
4. V. Chandran and S. P. Raychaudhuri, "Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis, " Journal of Autoimmunity, vol. 34, no. 3, pp. J314-J321, 2010.
5. A. Pietrzak, G. Chodorowska, J. Szepietowski, A. Zalewska- Janowska, D. Krasowska, and J. Hercogova, "Psoriasis and serum lipid abnormalities, " Dermatologic Therapy, vol. 23, no. 2, pp. 160-173, 2010.
6. M. P. Schön andW. -H. Boehncke, "Psoriasis, " The New England Journal of Medicine, vol. 352, no. 18, pp. 1899-1912, 2005.
7. S. Dogra and S. Yadav, "Psoriasis in India: prevalence and pattern, " Indian Journal ofDermatology, Venereology and Leprology, vol. 76, no. 6, pp. 595-601, 2010.
8. X. Ding, T. Wang, Y. Shen et al. , "Prevalence of psoriasis in China: a population-based study in six cities, " European Journal of Dermatology, vol. 22, no. 5, pp. 663-667, 2012.
9. R. D. R. Camp, "Psoriasis, " in Textbook of Dermatology, Blackwell Scientific Publications, Oxford, UK, 1992.
10. E. M. Farber and L. Nall, "Epidemiology: natural history and genetics, " in Psoriasis, MarcelDekker, New York, NY, USA, 1991.
11. K. D. Wuepper, S. N. Coulter, and A. Haberman, "Psoriasis vulgaris: a genetic approach, " Journal of Investigative Dermatology, vol. 95, no. 5, pp. 2S-4S, 1990.
12. D. L. Duffy, L. S. Spelman, and N. G. Martin, "Psoriasis in Australian twins, " Journal of the American Academy of Dermatology, vol. 29, no. 3, pp. 428-434, 1993.
13. T. Henseler, "Genetics of psoriasis, " Archives of Dermatological Research, vol. 290, no. 9, pp. 463-476, 1998.
14. J. N. W. N. Barker, "Genetic aspects of psoriasis, " Clinical and Experimental Dermatology, vol. 26, no. 4, pp. 321-325, 2001.
15. J. T. Elder, R. P. Nair, T. Henseler et al. , "The genetics of psoriasis 2001: the odyssey continues, " Archives of Dermatology, vol. 137, no. 11, pp. 1447-1454, 2001.
16. A. M. Bowcock and J. N. Barker, "Genetics of psoriasis: the potential impact on new therapies, " Journal of the American Academy of Dermatology, vol. 49, no. 2, pp. S51-S56, 2003.
17. D. Jullien and J. N. Barker, "Genetics of psoriasis, " Journal of the European Academy of Dermatology and Venereology, vol. 20, no. 2, pp. 42-51, 2006.
18. Y. Liu, C. Helms, W. Liao et al. , "A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci, " PLoS Genetics, vol. 4, no. 4, Article ID e1000041, 2008.
19. R. P. Nair, K. C. Duffin, C. Helms et al. , "Genome-wide scan reveals association of psoriasiswith IL-23 andNF-Bpathways, " Nature Genetics, vol. 41, no. 2, pp. 199-204, 2009.
20. U. Hüffmeier, S. Uebe, A. B. Ekici et al. , "Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis, " Nature Genetics, vol. 42, no. 11, pp. 996- 999, 2010.
21. K. Fogh, T. Herlin, and K. Kragballe, "Eicosanoids in acute and chronic psoriatic lesions: leukotriene B4, but not 12-hydroxyeicostatetraenoic acid, is present in biologically active amounts in acute guttate lesions, " Journal of Investigative Dermatology, vol. 92, no. 6, pp. 837-841, 1989.
22. A. Pietrzak, J. Kadzielewski, K. Janowski et al. , "Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity, " International Journal of Dermatology, vol. 48, no. 4, pp. 379-387, 2009.
23. A. Pietrzak, I. Jastrzebska, D. Krasowska et al. , "Serum pancreatic lipase [EC 3. 1. 1. 3] activity, serumlipid profile and peripheral blood dendritic cell populations in normolipidemic males with psoriasis, " Journal of Molecular Catalysis B, vol. 40, no. 3-4, pp. 144-154, 2006.
24. A. Pietrzak and B. Lecewicz-Torun, "Activity of serum lipase [EC 3. 1. 1. 3] and the diversity of serum lipid profile in psoriasis, " Medical Science Monitor, vol. 8, no. 1, pp. CR9-CR13, 2002.
25. P. Rocha-Pereira, A. Santos-Silva, I. Rebelo, A. Figueiredo, A. Quintanilha, and F. Teixeira, "Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease, " Clinica Chimica Acta, vol. 303, no. 1-2, pp. 33-39, 2001.
26. B. V. Kural, A. Orem, G. C imsit, H. A. Uydu, Y. E. Yandi, and A. Alver, "Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients, " Clinica Chimica Acta, vol. 332, no. 1-2, pp. 23-30, 2003.
27. J. L. Breslow, "Apolipoprotein genetic variation and human disease, " Physiological Reviews, vol. 68, no. 1, pp. 85-132, 1988.
28. R. W. Mahley and S. C. Rall Jr. , "Apolipoprotein E: far more than a lipid transport protein, " Annual Review of Genomics and Human Genetics, vol. 1, pp. 507-537, 2000.
29. K. Greenow, N. J. Pearce, and D. P. Ramji, "The key role of apolipoprotein E in atherosclerosis, " Journal of Molecular Medicine, vol. 83, no. 5, pp. 329-342, 2005.
30. R. J. Havel, N. Yamada, and D. M. Shames, "Role of apolipoprotein E in lipoprotein metabolism, "The American Heart Journal, vol. 113, no. 2, part 2, pp. 470-474, 1987.
31. N. Yamada, H. Shimano, and Y. Yazaki, "Role of apolipoprotein E in lipoprotein metabolism and in the process of atherosclerosis, " Journal of Atherosclerosis andThrombosis, vol. 2, supplement 1, pp. S29-S33, 1995.
32. D. Kothapalli, I. Fuki, K. Ali et al. , "Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation, " Journal of Clinical Investigation, vol. 113, no. 4, pp. 609-618, 2004.
33. P. van den Elzen, S. Garg, L. Leon et al. , "Apolipoproteinmediated pathways of lipid antigen presentation, " Nature, vol. 437, no. 7060, pp. 906-910, 2005.
34. M. E. Kelly, M. A. Clay, M. J. Mistry, H. -M. Hsieh-Li, and J. A. K. Harmony, "Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity, " Cellular Immunology, vol. 159, no. 2, pp. 124-139, 1994.
35. T. Koga, H. Duan, K. Urabe, andM. Furue, "In situ localization of CD83-positive dendritic cells in psoriatic lesions, " Dermatology, vol. 204, no. 2, pp. 100-103, 2002.
36. M. J. Artiga, M. J. Bullido, I. Sastre et al. , "Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene, " FEBS Letters, vol. 421, no. 2, pp. 105-108, 1998.
37. G. Utermann, M. Hees, and A. Steinmetz, "Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man, " Nature, vol. 269, no. 5629, pp. 604-607, 1977.
38. D. M. Hatters, C. A. Peters-Libeu, and K. H. Weisgraber, "Apolipoprotein E structure: insights into function, " Trends in Biochemical Sciences, vol. 31, no. 8, pp. 445-454, 2006.
39. H. Miyauchi, "Immunohistochemical study for the localization of apolipoprotein AI, B100, and E in normal and psoriatic skin, " Igaku Kenkyu, vol. 61, no. 2, pp. 79-86, 1991.
40. A. Karpouzis, R. Caridha, G. Tripsianis, C. Michailidis, G. Martinis, and S. V. Veletza, "Apolipoprotein e gene polymorphism in psoriasis, " Archives of Dermatological Research, vol. 301, no. 6, pp. 405-410, 2009.
41. H. Furumoto, K. Nakamura, T. Imamura et al. , "Association of apolipoprotein allele2 with psoriasis vulgaris in Japanese population, " Archives of Dermatological Research, vol. 289, no. 9, pp. 497-500, 1997.
42. J. L. Wang, E. H. Dai, J. Y. Wu et al. , "Study of the association of apolipoprotein E allelles and blood plasma lipoprotein levels with psoriasis vulgaris, "The Chinese Journal of Dermatovenereology, vol. 15, pp. 229-230, 2001.
43. Y. Liang, "The correlation between apolipoprotein E polymorphism and serum lipid in psoriasis vulgaris, " Zhong Nan University, pp. 1-16, 2003.
44. A. H. hang, L. Q. Zhang, G. Q. Liu et al. , "Investigation of the correlation between apolipoprotein allele 2 and psoriasis vulgaris, "The Chinese Journal of Dermatovenereology, vol. 19, pp. 460-462, 2005.
45. E. Campalani, M. H. Allen, D. Fairhurst et al. , "Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin, " British Journal of Dermatology, vol. 154, no. 2, pp. 345-352, 2006.
46. H. -L. Zhang and J. Wu, "Apolipoprotein E4 and psoriasis, " Archives of Dermatological Research, vol. 302, no. 2, p. 151, 2010.
47. P. Coto-Segura, E. Coto, V. Alvarez, and J. Santos-Juanes, "Apolipoprotein4 allele is associated with psoriasis severity: reply, " Archives of Dermatological Research, vol. 302, no. 3, pp. 237-238, 2010.
48. Y. Han, T. Liu, and L. Lu, "Apolipoprotein E gene polymorphism in psoriasis: a meta-analysis, " Archives of Medical Research, vol. 44, no. 1, pp. 46-53, 2013.
49. J. Schmitt andG. Wozel, "Thepsoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis, " Dermatology, vol. 210, no. 3, pp. 194-199, 2005.
50. K. U. Schallreuter, C. Levenig, P. Kuhnl, C. Loliger, M. Hohl- Tehari, and J. Berger, "Histocompatibility antigens in vitiligo: hamburg study on 102 patients from Northern Germany, " Dermatology, vol. 187, no. 3, pp. 186-192, 1993.
51. A. Svejgaard, P. Platz, and L. P. Ryder, "HLAand disease 1982-a survey, " Immunological Reviews, vol. 70, no. 1, pp. 193-218, 1983.
52. M. Seishima, M. Seishima, S. Hua, A. Abe, and A. Noma, "Apo E phenotype does not contribute to the pathogenesis of psoriasis, " British Journal of Dermatology, vol. 132, no. 1, pp. 169-171, 1995.
53. M. J. Mistry, M. A. Clay, M. E. Kelly, M. A. Steiner, and J. A. K. Harmony, "Apolipoprotein E restricts interleukin-dependent T lymphocyte proliferation at the G1/G1 boundary, " Cellular Immunology, vol. 160, no. 1, pp. 14-23, 1995.
54. T. Imamura, I. Takata, K. Tominaga, T. Yamamoto, M. Ogasawara, and C. Asagami, "Apolipoprotein E phenotypes and psoriasis, " Nippon Hifuka Gakkai Zasshi, vol. 100, no. 9, pp. 923- 928, 1990.
55. S. H. Hsia, P. W. Connelly, and R. A. Hegele, "Restriction isotyping of apolipoprotein E R145C in type III hyperlipoproteinemia, " Journal of Investigative Medicine, vol. 43, no. 2, pp. 187-194, 1995.
56. R. Coudere, F. Mahieux, S. Bailleul, G. Fenelon, R. Mary, and J. Fermanian, "Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease: a case-control study, " Stroke, vol. 24, no. 5, pp. 661-664, 1993.
57. W. B. Grant, "Amulticountry ecological study of risk-modifying factors for prostate cancer: apolipoprotein E4 as a risk factor and cereals as a risk reduction factor, " Anticancer Research, vol. 30, no. 1, pp. 189-199, 2010.
58. J. L. Oestreicher, I. B. Walters, T. Kikuchi, and P. Gilleaudeau, "Molecular classification of psoriasis diseaseassociated genes through pharmacogenomic expression profiling, " Pharmacogenomics Journal, vol. 1, no. 4, pp. 272-287, 2001.
59. C. Vahlquist, G. Michaelsson, and B. Vessby, "Serum lipoproteins in middle-aged men with psoriasis, " Acta Dermato- Venereologica, vol. 67, no. 1, pp. 12-15, 1987.
60. M. Seishima, M. Seishima, S. Mori, and A. Noma, "Serum lipid and apolipoprotein levels in patients with psoriasis, " British Journal of Dermatology, vol. 130, no. 6, pp. 738-742, 1994.
61. M. Akhyani, A. H. Ehsani, R. M. Robati, and A. M. Robati, "The lipid profile in psoriasis: a controlled study, " Journal of the European Academy of Dermatology and Venereology, vol. 21, no. 10, pp. 1330-1332, 2007.
62. M. A. Aldhalimi, S. J. Almuhanna, and S. H. Alrikabi, "Serum lipid level in Iraqi patients with psoriasis, " Skinmed, vol. 8, no. 4, pp. 204-206, 2010.
63. C. J. McDonald and P. Calabresi, "Psoriasis and occlusive vascular disease, " British Journal of Dermatology, vol. 99, no. 5, pp. 469-475, 1978.
64. D. Seckin, L. Tokgozoglu, and S. Akkaya, "Are lipoprotein profile and lipoprotein (a) levels altered in men with psoriasis?" Journal of the American Academy of Dermatology, vol. 31, no. 3, pp. 445-449, 1994.
65. S. -K. Lin, J. -T. Kao, S. -M. Tsai et al. , "Association of apolipoprotein E genotypes with serum lipid profiles in a healthy population of Taiwan, " Annals of Clinical and Laboratory Science, vol. 34, no. 4, pp. 443-448, 2004.
66. S. Liang, M. Pan, H. -H. Geng et al. , "Apolipoprotein e polymorphism in normal HanChinese population: frequency and effect on lipid parameters, " Molecular Biology Reports, vol. 36, no. 6, pp. 1251-1256, 2009.
67. R. O. Alvim, S. R. Freitas, N. E. Ferreira et al. , "APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population, " Lipids inHealth andDisease, vol. 9, article 128, 2010.
68. P. Hu, Y. H. Qin, F. Y. Lei, J. Pei, B. Hu, and L. Lu, "Variable frequencies of apolipoprotein E genotypes and its effect on serum lipids in the Guangxi Zhuang and Han children, " International Journal ofMolecular Sciences, vol. 12, no. 9, pp. 5604-5615, 2011.
69. D. I. Chasman, P. Kozlowski, R. Y. Zee, D. J. Kwiatkowski, and P. M. Ridker, "Qualitative and quantitative effects ofAPOE genetic variation on plasma C-reactive protein, LDL-cholesterol, and apoE protein, " Genes and Immunity, vol. 7, no. 3, pp. 211-219, 2006.